Boston Scientific to acquire Bayer unit for $415M

Boston Scientific (BSX) has agreed to acquire Bayer's (BAYRY) Interventional device business for $415M.

The deal that will strengthen Boston's portfolio of products for treating peripheral vascular disease, with the company to receive systems used in cardiology, radiology and peripheral vascular procedures.

The unit generated $120M in sales last year. (PR)

From other sites
Comments (1)
  • Roxieanne
    , contributor
    Comments (1049) | Send Message
    I missed the article about the Bayer unit acquisition. Is this the Bayer that makes aspirin.
    1 Sep 2014, 03:15 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs